EUVIMEDEUVIMED entdecken
Crossref

Use of rituximab in rheumatic diseases beyond the indications listed in the Summary of Product Characteristics

Dorota Piłat, Gabriela Zemanek, Jan Kurdybacha, Oleksii Kravets, Natalia Leszczyńska, Michał Furtak, Monika Roszkowska, Martyna Biedasiewicz, Aleksandra Pytlarz, Natalia Lekston, Przemysław Kotyla

Rheumatology Forum · 11.03.2026 · 12

DOI: 10.5603/rf.111727 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology Forum, online erschienen am 11.03.2026. Verfasst von Dorota Piłat und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Piłat, D., Zemanek, G., Kurdybacha, J., Kravets, O., Leszczyńska, N., Furtak, M., Roszkowska, M., Biedasiewicz, M., Pytlarz, A., Lekston, N., & Kotyla, P. (2026). Use of rituximab in rheumatic diseases beyond the indications listed in the Summary of Product Characteristics. Rheumatology Forum, 12(0). https://doi.org/10.5603/rf.111727

Vancouver

Piłat D, Zemanek G, Kurdybacha J, Kravets O, Leszczyńska N, Furtak M, et al. Use of rituximab in rheumatic diseases beyond the indications listed in the Summary of Product Characteristics. Rheumatology Forum. 2026;12(0). doi:10.5603/rf.111727

BibTeX
@article{Piat2026,
  author = {Piłat, Dorota and Zemanek, Gabriela and Kurdybacha, Jan and Kravets, Oleksii and Leszczyńska, Natalia and Furtak, Michał and Roszkowska, Monika and Biedasiewicz, Martyna and Pytlarz, Aleksandra and Lekston, Natalia and Kotyla, Przemysław},
  title = {Use of rituximab in rheumatic diseases beyond the indications listed in the Summary of Product Characteristics},
  journal = {Rheumatology Forum},
  year = {2026},
  volume = {12},
  number = {0},
  doi = {10.5603/rf.111727}
}
Kostenlos starten →